Clinical Trials
5
Active:0
Completed:2
Trial Phases
3 Phases
Phase 1:2
Phase 2:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (40.0%)Phase 2
2 (40.0%)Not Applicable
1 (20.0%)A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age
Not Applicable
Not yet recruiting
- Conditions
- Viral Respiratory InfectionViral Respiratory Illnesses
- Interventions
- Other: Placebo
- First Posted Date
- 2025-10-30
- Last Posted Date
- 2025-10-30
- Lead Sponsor
- ENA Respiratory Pty Ltd
- Target Recruit Count
- 1100
- Registration Number
- NCT07222670
INNA-051 Influenza Challenge Study
- First Posted Date
- 2022-02-25
- Last Posted Date
- 2023-01-18
- Lead Sponsor
- ENA Respiratory Pty Ltd
- Target Recruit Count
- 123
- Registration Number
- NCT05255822
- Locations
- 🇬🇧
hVIVO, London, United Kingdom
Intranasal INNA-051 for Prevention of COVID-19 in Adults
- First Posted Date
- 2021-11-12
- Last Posted Date
- 2022-04-14
- Lead Sponsor
- ENA Respiratory Pty Ltd
- Registration Number
- NCT05118763
News
No news found